Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6381)	11/29/1998 9:00:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

On December 1st and 2nd, the FDA's Arthritis Advisory Committee will meet to discuss Celebrex for the treatment and management of OA, RA and pain. fda.gov In "celebrextion" of this meeting, here is the PFEr question of the week: What will be the impact of a possible Celebrex approval on PFE? Have PFun! Big KNY3 Reference Links Celebrex FDA Review in December news.com Monsanto Seeks Approval of First Cox-II news.com Celebrex Effective With Few Side Effects news.com Vioxx and Celebrex Work Well news.com